Lingkang Pharmaceutical announced that its wholly-owned subsidiary Hainan Lingkang Pharmaceutical Co., Ltd. received the “Drug Registration Certificate” for naloxone hydrochloride injections approved and issued by the State Drug Administration. This medication is suitable for completely or partially reversing opioid suppression caused by natural and synthetic opioids, including respiratory depression.

Zhitongcaijing · 03/11/2025 08:33
Lingkang Pharmaceutical announced that its wholly-owned subsidiary Hainan Lingkang Pharmaceutical Co., Ltd. received the “Drug Registration Certificate” for naloxone hydrochloride injections approved and issued by the State Drug Administration. This medication is suitable for completely or partially reversing opioid suppression caused by natural and synthetic opioids, including respiratory depression.